- Home
- PRME vs PACB Comparison
PRME vs PACB Comparison
Compare PRME & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRME | PACB |
|---|---|---|
| Founded | 2019 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 666.1M | 555.5M |
| IPO Year | 2022 | 2010 |
Fundamental Metrics
Financial Performance| Metric | PRME | PACB |
|---|---|---|
| Price | $4.04 | $2.14 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $6.42 | $2.08 |
| AVG Volume (30 Days) | 3.7M | ★ 6.3M |
| Earning Date | 02-27-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $5,977,000.00 | ★ $154,584,000.00 |
| Revenue This Year | $111.80 | $4.48 |
| Revenue Next Year | N/A | $11.99 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 647.13 | N/A |
| 52 Week Low | $1.11 | $0.85 |
| 52 Week High | $6.94 | $2.73 |
Technical Indicators
Market Signals| Indicator | PRME | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 58.09 | 56.70 |
| Support Level | $3.29 | $1.67 |
| Resistance Level | $4.12 | $1.89 |
| Average True Range (ATR) | 0.25 | 0.12 |
| MACD | 0.04 | 0.02 |
| Stochastic Oscillator | 86.93 | 82.73 |
Price Performance
Historical ComparisonAbout PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.